Oscar Health Stock Surges on Medicare Reimbursement Boost
Oscar Health Inc. extended its winning streak to a sixth consecutive day, jumping 12.88 percent to close at $14.64 after the Centers for Medicare and Medicaid Services announced significantly higher reimbursement rates for Medicare Advantage plans in 2027. The CMS raised rates to 2.48 percent, a substantial increase from the 0.09 percent announced in January, translating to more than $13 billion in additional payments across the industry. As a leading insurance provider offering Medicare plans, Oscar Health is well positioned to benefit from this favorable regulatory decision. The company projects full-year 2026 revenue growth of 60 to 62 percent, targeting $18.7 billion to $19 billion compared to $11.7 billion in 2025.
